These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 37935376)
21. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders. Wu R; Li JX CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253 [TBL] [Abstract][Full Text] [Related]
22. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine. Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617 [TBL] [Abstract][Full Text] [Related]
23. In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1. Simmler LD; Buchy D; Chaboz S; Hoener MC; Liechti ME J Pharmacol Exp Ther; 2016 Apr; 357(1):134-44. PubMed ID: 26791601 [TBL] [Abstract][Full Text] [Related]
31. Discovery of potential TAAR1 agonist targeting neurological and psychiatric disorders: An in silico approach. Garisetti V; Dhanabalan AK; Dasararaju G Int J Biol Macromol; 2024 Apr; 264(Pt 2):130528. PubMed ID: 38431013 [TBL] [Abstract][Full Text] [Related]
32. Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling. Grossi G; Scarano N; Musumeci F; Tonelli M; Kanov E; Carbone A; Fossa P; Gainetdinov RR; Cichero E; Schenone S Molecules; 2024 Apr; 29(8):. PubMed ID: 38675561 [TBL] [Abstract][Full Text] [Related]
33. Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry? Dodd S; F Carvalho A; Puri BK; Maes M; Bortolasci CC; Morris G; Berk M Neurosci Biobehav Rev; 2021 Jan; 120():537-541. PubMed ID: 33031817 [TBL] [Abstract][Full Text] [Related]
35. Molecular recognition of an odorant by the murine trace amine-associated receptor TAAR7f. Gusach A; Lee Y; Khoshgrudi AN; Mukhaleva E; Ma N; Koers EJ; Chen Q; Edwards PC; Huang F; Kim J; Mancia F; Veprintsev DB; Vaidehi N; Weyand SN; Tate CG Nat Commun; 2024 Aug; 15(1):7555. PubMed ID: 39215004 [TBL] [Abstract][Full Text] [Related]
36. AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1. Díaz-Holguín A; Saarinen M; Vo DD; Sturchio A; Branzell N; Cabeza de Vaca I; Hu H; Mitjavila-Domènech N; Lindqvist A; Baranczewski P; Millan MJ; Yang Y; Carlsson J; Svenningsson P Sci Adv; 2024 Aug; 10(32):eadn1524. PubMed ID: 39110804 [TBL] [Abstract][Full Text] [Related]
37. New insights into the structure of the trace amine-associated receptor 2: Homology modelling studies exploring the binding mode of 3-iodothyronamine. Cichero E; Tonelli M Chem Biol Drug Des; 2017 May; 89(5):790-796. PubMed ID: 27863038 [TBL] [Abstract][Full Text] [Related]
38. Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class. Lewin AH; Miller GM; Gilmour B Bioorg Med Chem; 2011 Dec; 19(23):7044-8. PubMed ID: 22037049 [TBL] [Abstract][Full Text] [Related]
39. Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1. Cöster M; Biebermann H; Schöneberg T; Stäubert C Eur Thyroid J; 2015 Sep; 4(Suppl 1):9-20. PubMed ID: 26601069 [TBL] [Abstract][Full Text] [Related]
40. Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges. Berry MD; Gainetdinov RR; Hoener MC; Shahid M Pharmacol Ther; 2017 Dec; 180():161-180. PubMed ID: 28723415 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]